From Lab to Bedside Evolution of Point of Care Molecular Diagnostics
The Point-of-Care Molecular Diagnostics Market size was valued at USD 4.37 billion in 2022 and is projected to grow from USD 5.02 billion in 2023 to USD 13.26 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.90% during the forecast period (2023 - 2030). In the ever-evolving landscape of healthcare, rapid and accurate diagnostic tools are crucial for effective patient...
0 0 Comments 0 Shares